Barts

London EC1M6BQ

1 studies enrolling now · 3 studies all time

What they study most

Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers, Cardiovascular, Dyslipidemias, Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH), Hypercholesterolaemia, Hypertriglyceridemia, Lipid Disorder, Metabolic Disease, Mixed Hyperlipemia, Severe Hypertriglyceridemia (sHTG), Triple Negative Breast Neoplasms

Studies at this site

• A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias — Recruiting now
• A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer — Completed
• Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors — Stopped early